Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OlaWell was a U.S.-based digital health and microbiome testing company focused on consumer gut microbiome analysis and personalized nutrition recommendations. The company marketed at-home gut microbiome test kits that used DNA sequencing and proprietary algorithms to generate reports on microbiome composition, food sensitivities, and dietary guidance. Its offering appears to have been positioned as a wellness and preventive health product rather than a therapeutics pipeline company, with results delivered through a digital reporting and app-based experience. Available third-party sources indicate the business was founded around 2018, operated from Massachusetts, partnered with LifeOmic for data integration, and was later described by startup databases as no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OlaWell.